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ABSTRACT
Background: The use of electronic cigarettes (ECs) has increased drastically over
the past five years, primarily as an alternative to smoking tobacco cigarettes.
However, the adverse effects of acute and long-term use of ECs on the microbiota
have not been explored. In this pilot study, we sought to determine if ECs or
tobacco smoking alter the oral and gut microbiota in comparison to non-smoking
controls.
Methods: We examined a human cohort consisting of 30 individuals: 10 EC users,
10 tobacco smokers, and 10 controls. We collected cross-sectional fecal, buccal
swabs, and saliva samples from each participant. All samples underwent V4 16S
rRNA gene sequencing.
Results: Tobacco smoking had a significant effect on the bacterial profiles in all
sample types when compared to controls, and in feces and buccal swabs when
compared to EC users. The most significant associations were found in the gut, with
an increased relative abundance of Prevotella (P = 0.006) and decreased Bacteroides
(P = 0.036) in tobacco smokers. The Shannon diversity was also significantly
reduced (P = 0.009) in fecal samples collected from tobacco smokers compared to
controls. No significant difference was found in the alpha diversity, beta-diversity or
taxonomic relative abundances between EC users and controls.
Discussion: From a microbial ecology perspective, the current pilot data
demonstrate that the use of ECs may represent a safer alternative compared to
tobacco smoking. However, validation in larger cohorts and greater understanding
of the short and long-term impact of EC use on microbiota composition and
function is warranted.
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INTRODUCTION
Tobacco cigarettes are the leading cause of preventable diseases in the world (Cahn &
Siegel, 2011). Smoking increases the risk for development of several diseases, including
cardiovascular disease (Lubin et al., 2016), various cancers (Jacobs et al., 2015),
especially lung cancer (Montserrat-Capdevila et al., 2016), and inflammatory bowel
disease (Higuchi et al., 2012). Electronic cigarettes (ECs) offer promise as a tool to quit
or an alternative to tobacco smoking. It is estimated that over 12% of adults in the
US have used ECs (Kosmider et al., 2016). Use of ECs is tripling annually with consumers
including non-tobacco smoking adolescents and adults (Moon, Lee & Lee, 2015;
Bostean, Trinidad & McCarthy, 2015). While ECs primarily contain propylene glycol,
vegetable glycerin, and nicotine, tobacco cigarettes are composed of over 4,000 other
chemicals and particulate matter (You et al., 2015). Studies reporting negative health
effects relating to ECs are scarce and ECs remain unregulated, but commercial ECs have
been reported to contain low levels of toxic compounds (Cahn & Siegel, 2011; Varlet et al.,
2015; Kosmider et al., 2016; Allen et al., 2016).
There are relatively few studies exploring the effects of tobacco smoke on the
microbiota and we are not aware of any study to date that has compared the bacterial
communities in tobacco smokers and EC users. In one human study, the oral microbiota
was altered between healthy non-smokers and tobacco smokers, with decreased
Porphyromonas, Neisseria, and Gemella in tobacco smokers, but the lung communities
were not affected (Morris et al., 2013). Smoking has also been shown to drive changes in
the sputum microbiota more than other lifestyle factors (e.g., exercise and alcohol),
increasing the relative abundance of Veillonella and Megasphaera (Lim et al., 2016). A
recent large-scale sequencing study of the oral microbiota in current, previous, or non-
smokers demonstrated current smokers had distinct oral communities, with reduced
relative abundance of Proteobacteria (Wu et al., 2016). Notably, the significant taxa vary
between studies and a recent analysis of numerous sites within the mouth found no
significant difference between smokers and controls in any site, with the exception of the
buccal mucosa (Yu et al., 2017). Quitting smoking has been shown to increase bacterial
diversity and alter community composition in both the mouth (Delima et al., 2010) and
gut (Biedermann et al., 2013). Besides human cohort research, the gut microbiota has been
shown to differ in tobacco smoke exposed mice, in comparison to air-only exposure
(Wang, 2012; Allais et al., 2016).
The current study represents the first exploration of the effect of EC vapor and tobacco
smoke exposure on the oral (buccal and saliva) and gut bacterial communities.
MATERIALS AND METHODS
Study design and cohort
The study was approved by the Baylor College of Medicine Institutional Review Board
(IRB H-38043). Written informed consent was obtained prior to collection of data
and samples.
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The cohort consisted of 30 individuals in three distinct exposure groups; EC users
(n = 10), tobacco smokers (n = 10), and matched controls (n = 10). All participants
were recruited from the Houston area. Inclusion criteria for EC users included daily
use of ECs for at least six months. Inclusion criteria for tobacco smokers included an
Fagerstrom test for nicotine dependence 4 and smoked a minimum of 10 cigarettes
per day. Subject variables between the three exposure groups were comparable, with
no significant difference in the sex, age, diet, height/weight, or race (Table 1). Notably,
only 2/30 samples were from female participants. One EC user (EC7) reported
occasionally smoking one tobacco cigarette per week and no other EC users reported use
of tobacco cigarettes. EC7 had a comparable carbon monoxide (CO) ppm to other EC
users and controls. No tobacco smokers reported use of EC. EC users vaped regularly
throughout the day, used ECs daily, and had been actively using ECs for a median of three
years.
DNA extraction
DNA was extracted from 125 mg of fresh fecal samples using the AllPrep Bacterial kit
(Mo Bio 47054; Mo Bio Laboratories, Carlsbad, CA, USA) as per the manufacturers’
protocol. Entire buccal swabs and 500 ml saliva samples were extracted using the
Table 1 Subject information for the human cohort per exposure group.
Controls Electronic
cigarette
Tobacco
smoke
Male sex 90% 90% 100%
Age in years, median (IQR) 31 (28–36) 29 (24–37) 35 (30–45)
Diet
Meat eater 90% 90% 100%
Vegetarian 10% 0 0
Vegan 0 10% 0
Body mass index, median (IQR) 23.5 (22.5–24.5) 24.5 (22.5–26.7) 24 (21.5–25.5)
Race
White 60% 70% 60%
Hispanic 10% 20% 10%
Asian 30% 10% 0
Black 0 0 30%
Electronic cigarette
Nicotine concentration (mg),
median (IQR)
– 9 (6–12) –
Volume (ml)/day, median (IQR) – 8 (3–19) –
Years using, median (IQR) – 3 (2–4) –
Tobacco smoke
Cigarettes/day, median (IQR) 0 0.2 (0.2–0.2) 14 (10–19)
FTND, median (IQR) 0 0 5 (4-6)
Carbon monoxide (ppm), median (IQR) 1 (1–2) 3 (3–4) 19 (14–24)
Note:
IQR, interquartile range; FTND, Fagerstrom test for nicotine dependence.
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PowerMicrobiome RNA isolation kit (Mo Bio 26000-50; Mo Bio Laboratories, Carlsbad,
CA, USA) as per the manufacturers’ protocol, omitting the necessary steps for co-elution
of DNA and RNA, and with elution of nucleic acids in 50 ml.
16S rRNA gene sequencing
The bacterial 16S rRNA gene V4 region was amplified by PCR using barcoded Illumina
adapter-containing primers 515F and 806R (Caporaso et al., 2012) and sequenced with the
2  250 bp cartridges in the MiSeq platform (Illumina, San Diego, USA). The read pairs
were demultiplexed and reads were merged using USEARCH v7.0.1090 (Edgar, 2010).
Merging allowed zero mismatches and a minimum overlap of 50 bases, and merged
reads were trimmed at the first base with a Q 5. A quality filter was applied to the resulting
merged reads and those containing above 0.5% expected errors were discarded. Sequences
were stepwise clustered into operational taxonomic units (OTUs) at a similarity cutoff value
of 97% using the UPARSE algorithm (Edgar, 2013). Chimeras were removed using
USEARCH v7.0.1090 and UCHIME. To determine taxonomies, OTUs were mapped to a
version of the SILVA database (Quast et al., 2013) containing only the 16S V4 region using
USEARCH v7.0.1090. Abundances were recovered by mapping the merged reads to the
UPARSEOTUs. A rarefiedOTU table was constructed from the output files generated in the
previous two steps for downstream analyses of alpha diversity, beta diversity (including
UniFrac), and phylogenetic trends (Lozupone & Knight, 2005).
Statistical analysis
Samples were rarefied to 4,000 reads and rarefaction resulted in the loss of all negative
controls for each DNA extraction kit. Analysis and visualization of bacterial communities
was conducted in R (R Development Core Team, 2014). For analysis of alpha diversity
and taxonomic relative abundance, the Kruskal–Wallis test (Kruskal & Wallis, 1952)
was first applied to determine the overall statistical significance of the three groups. Only
if the Kruskal–Wallis test showed a P < 0.05, pairwise significance was determined based
on the Mann–Whitney test (Mann & Whitney, 1947). Differences in beta diversity
(weighted Unifrac distance) were assessed using PERMANOVA. Linear regression was
performed in R using the lm() function. When comparing more then one measure, such
as multiple measures of alpha diversity or for multiple taxonomic genera, P-values were
adjusted for multiple comparisons with the false discovery rate (FDR) algorithm
(Benjamini & Hochberg, 1995).
All data and metadata files, as well as the R code used in the analysis, are provided in
the Supplemental Information.
RESULTS
Microbiota specific to sample site
Feces had a distinct bacterial profile compared to the oral samples (buccal swab and
saliva) (Fig. S1A). The Shannon diversity indices showed a significant increase in saliva
(P < 0.001) and feces (P < 0.001) in comparison to buccal swab samples (Fig. S1B).
Dominant bacterial genera were also significantly different (P < 0.001) between the three
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sample types (Fig. S1C). Thus, analyses exploring the effects of tobacco smoking or
EC use were stratified by sample type.
Alpha diversity of feces is reduced in tobacco smokers
The Shannon diversity was significantly reduced in fecal samples collected from tobacco
smokers compared to controls (P = 0.009), but the number of observed OTUs was
comparable between all groups (Fig. 1A). No significant difference was found in the
number of OTUs or Shannon diversity between the groups in buccal swabs and saliva
samples (Figs. 1B and 1C).
Bacterial profiles of feces and oral sites are significantly altered in
tobacco smokers
Weighted UniFrac PCoA, a quantitative distance metric incorporating phylogenetic
distances between taxa, showed tobacco smokers had significantly altered fecal bacterial
profiles compared to controls (P = 0.027) and EC users (P = 0.009), but controls
and EC users were not significantly different (P = 0.261) (Fig. 2A). This was consistent
in buccal swabs, where bacterial profiles were significantly different between tobacco
smokers compared to controls (P = 0.049) and EC users (P = 0.033), but controls
and EC users were comparable (P = 0.886) (Fig. 2B). In saliva samples, the microbiota
profiles of tobacco smokers and controls were significantly different (P = 0.046) and
EC users were comparable to both tobacco smokers and controls (Fig. 2C).
The relative abundance of bacterial genera was significantly
associated with tobacco smoking in feces only
Fecal samples had a total of two genera significantly different between the three groups,
with increased Prevotella (P = 0.006) and decreased Bacteroides (P = 0.036) in tobacco
smokers (Fig. 3). Further pairwise comparisons of these genera showed Prevotella had
significantly increased relative abundance in tobacco smokers compared to controls
(P = 0.008) and EC users (P = 0.003), but no difference between EC users and controls
(P = 0.99). Whereas Bacteroides showed significantly decreased relative abundance in
tobacco smokers compared to controls (P = 0.017) and EC users (P = 0.003), but no
difference between EC users and controls (P = 0.684). No significant difference in any
bacterial genera was observed between the different groups in saliva or buccal swab
samples (Fig. S2). These findings were also supported by correlations with CO levels,
which reflect the amount an individual smoked tobacco cigarettes. Specifically, no genus
was significantly associated with saliva or buccal swab samples, but Bacteroides was
negatively correlated with CO level (P = 0.042) and Prevotella was positively correlated
with CO levels (P = 0.011) (Table S1; Fig. S3).
DISCUSSION
This pilot study aimed to characterize the effects of EC vapor and tobacco smoke exposure
on the bacterial profiles at multiple distinct and relevant body sites in a human cohort. To
our knowledge this work represents the first study to concurrently explore the effect of EC
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Figure 1 Boxplots of bacterial alpha diversity. Analysis stratified per sample type. Controls (Con;
orange); electronic cigarette (EC; blue); tobacco smoke (TS; green). Significance based on non-parametric
Mann–Whitney test with FDR adjustment for multiple comparisons. Number of operational taxonomic
units (OTUs) (A) and Shannon diversity (B) in feces. Number of OTUs (C) and Shannon diversity
(D) in buccal swabs. Number of OTUs (E) and Shannon diversity (F) in saliva.
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vapor and tobacco smoke exposure on the microbiota. With users of ECs increasing at an
unprecedented rate, it is imperative to understand the potential influences on host well-
being, for which the oral and gut microbiota may have important consequences.
We report, for the first time, that regular use of ECs does not measurably influence oral
or gut bacterial communities. However, compared to controls, tobacco smoking had a
significant effect on the bacterial profiles in all samples analyzed, with the most significant
associations found in the gut. This is in accordance with existing data showing the gut
microbiota changes following smoking cessation (Biedermann et al., 2013, 2014).
This is reflected in the alpha diversity analyses, where the fecal microbiota of tobacco
smokers had significantly reduced Shannon diversity compared to controls. Previous
studies have also showed the Shannon diversity is reduced in tobacco smokers compared
to matched non-smokers in the gut (Opstelten et al., 2016), but recovers upon smoking
cessation (Biedermann et al., 2013). Although smoking was recently reported to reduce
buccal diversity (Yu et al., 2017), we found no difference in the diversity between the
groups in buccal swabs. Overall, such studies provide further evidence for a direct effect of
tobacco smoke in restricting microbial diversity and/or providing favorable conditions for
specific taxa. The reduced bacterial diversity in the gut was striking, which may have
important consequences for health and the risk of certain diseases. While inconclusive,
reduced bacterial diversity has been associated with a range of conditions, including
inflammatory bowel disease (Ott & Schreiber, 2006; Durba´n et al., 2012; Sha et al., 2013),
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Figure 3 Boxplot analysis of the bacterial genera in feces per exposure group. Genera ordered based
on lowest P value. All genera with >1% mean abundance included. Boxes represent interquartile ranges,
with lines denoting median. Controls (Con; orange); electronic cigarette (EC; blue); tobacco smoke (TS;
green). Kruskal–Wallis test with FDR adjustment for multiple comparisons showed two taxa sig-
nificantly altered in feces, Prevotella (P = 0.006) and Bacteroides (P = 0.036). Mann–Whitney pairwise
comparisons for Prevotella showed significantly increased relative abundance in TS compared to Con
(P = 0.008) and EC (P = 0.003), but no difference between EC and Con (P = 0.99). Mann–Whitney
Pairwise comparisons for Bacteroides showed significantly decreased relative abundance in TS compared
to Con (P = 0.017) and EC (P = 0.003), but no difference between EC and Con (P = 0.684).
Full-size DOI: 10.7717/peerj.4693/fig-3
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obesity (Turnbaugh et al., 2009), colorectal cancer (Ahn et al., 2013), and asthma
(Abrahamsson et al., 2014).
Only the fecal microbiota was found to have specific genera significantly altered by
exposure, with increased relative abundance of Prevotella, in accordance with existing data
(Benjamin et al., 2012). Conversely, smoking tobacco cigarettes significantly decreased the
relative abundance of Bacteroides compared to EC users and controls. Prevotella and
Bacteroides are dominant members of the human gut microbiome (Arumugam et al., 2011;
Koren et al., 2013;Gorvitovskaia, Holmes & Huse, 2016). Prevotella is associated with a high
fiber diet and living in rural conditions (De Filippo et al., 2010; Ou et al., 2013; Tyakht
et al., 2013; Kovatcheva-Datchary et al., 2015), whereas high Bacteroides abundance in
the gut is generally attributed to a protein, fat, and sugar rich diet and a Western lifestyle
(De Filippo et al., 2010; Ou et al., 2013). Prevotella and Bacteroides may have important
implications for health and disease, with several species of the Bacteroides genus
considered beneficial or probiotic (Xu & Gordon, 2003; Backhed et al., 2005). Existing
evidence suggests intestinal inflammation, such as in Crohn’s disease, is associated with
reduced abundance of Bacteroides (Guinane & Cotter, 2013). Furthermore, a reduced
Bacteroides abundance has been associated with obesity in both humans (Ley et al., 2006)
and mice (Ley et al., 2005; Turnbaugh et al., 2006) studies, but the direct role of the
microbiome in obesity causality remains an area of active discussion (Sze & Schloss, 2016).
Conversely, high Prevotella in the gut has been associated with human colon cancer (Chen
et al., 2012; Sivaprakasam et al., 2016) and susceptibility to colitis (Elinav et al., 2011;
Chow, Tang & Mazmanian, 2011).
No taxa were significantly altered in the oral (both buccal swab and saliva) microbiota.
These results were surprising given the immediate proximity of the oral environment,
relative to the gut, in smoke/vapor exposure. Indeed, smoking tobacco cigarettes has
previously been shown to significantly alter the bacterial community in oral and lung
samples (Charlson et al., 2010; Kozlowska et al., 2013; Mason et al., 2014; Wu et al., 2016).
Conversely, existing studies have also reported no changes in smokers (Morris et al., 2013)
and the taxa driving the separation vary between studies, which may reflect the
differences in cohorts or methods, such as in specific site of sample collection, extraction,
sequencing, and bioinformatics (Yu et al., 2017). Thus, further research in large
multi-location cohorts is necessary to ascertain the direct effects of smoking across
respiratory sites. Notably, both Prevotella and Bacteroides were highly specific to fecal
samples (Table S2; Fig. S3), further demonstrating the precise effects of tobacco smoke
exposure on taxa endogenous to the gut.
This study has several potential limitations. First, the cohort information was collected
by questionnaire and while one EC user reported occasional use of tobacco cigarettes (one
per week maximum), it is possible other participants used tobacco cigarettes and did not
report this. However, to control for this we tested the CO levels (reflective of smoke
inhalation) in all individuals and found tobacco smokers had higher CO ppm compared
to EC users and controls, which would be expected (Table 1). Second, it is possible that the
study was underpowered to detect subtle changes in the different sample sites and within
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some of the patient demographics. Third, only 2/30 participants in the study were female
and, given the potential for sex-specific microbiota profiles (Haro et al., 2016), additional
work is needed to determine if the findings differ between males and females. Further
longitudinal work with frequent sampling in larger human cohorts is needed to validate
the associations reported in this study and determine the potential mechanism and
impact on host health. Despite an absence of taxonomic change in EC vapor exposure,
determining potential changes to microbial and host functioning also represents an
important area for subsequent research.
CONCLUSION
In summary, we found that tobacco smoking significantly alters the bacterial profiles in
feces, buccal, and saliva samples. Compared to controls, exposure to ECs had no effect on
the oral or gut communities. Changes in the gut microbiota of tobacco smokers were
associated with increased relative abundance of Prevotella and decreased relative
abundance of Bacteroides. From a microbial ecology perspective, this study supports
the perception that ECs represent a safer alternative to tobacco smoking. However,
other end points besides the microbiota will be important to consider when
determining the impact of ECs on human health and disease. At a time when EC use
continues to rise, we highlight the need for greater understanding on the direct short
and long-term impact of exposure to vapor on the microbiome composition and
function.
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